G210-2844 Screening compound: N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,7-dimethyl-3-phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide

G210-2844 Screening compound: N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,7-dimethyl-3-phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide
G210-2844 Screening compound: N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,7-dimethyl-3-phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G210-2844
N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,7-dimethyl-3-phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G210-2844

Molecular Formula

C28H32N6O (C28 H32 N6 O)

Compound Name

N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,7-dimethyl-3-phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide

IUPAC name

N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-27-dimethyl-3-phenylpyrazolo[15-a]pyrimidine-6-carboxamide

SMILES

CCN1CCN(Cc(cc2)ccc2NC(c2c(C)n3nc(C)c(-c4ccccc4)c3nc2)=O)CC1

InChI

InChI=1S/C28H32N6O/c1-4-32-14-16-33(17-15-32)19-22-10-12-24(13-11-22)30-28(35)25-18-29-27-26(23-8-6-5-7-9-23)20(2)31-34(27)21(25)3/h5-13,18H,4,14-17,19H2,1-3H3,(H,30,35)

InChI Key

UOEGESMLHODWOW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27210882

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.6

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.927

Distribution Coefficient, logD

1.995

Water Solubility, LogSw

-3.30

Polar Surface Area

51.150

Acid Dissociation Constant (pKa)

10.36

Base Dissociation Constant (pKb)

8.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.10

G210-2844 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G210-2844 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G210-2844?
Check Price and Availability of G210-2844, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G210-2844 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G210-2844
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G210-2844
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G210-2844 available by request